MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ccd.29112

Медицинская библиотека · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2020

Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results.

Fraccaro Chiara, Campante Teles Rui, Tchétché Didier, Saia Francesco, Bedogni Francesco, Montorfano Matteo, Fiorina Claudia, Meucci Francesco, De Benedictis Mauro, Leonzi Ornella, Barbierato Marco, Dumonteil Nicolas, Stolcova Miroslava, Maffeo Diego, Compagnone Miriam, Brito João, Chieffo Alaide, Tarantini Giuseppe

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

OBJECTIVES

Aim of this study is to evaluate safety, feasibility, and mid-term outcome of transcatheter aortic valve implantation (TAVI) in cardiogenic shock (CS).

BACKGROUND

Balloon aortic valvuloplasty in patients with severe aortic valve stenosis (SAS) complicated by CS is indicated but associated with a grim prognosis. TAVI might be a more reasonable treatment option in this setting but data are scant.

METHODS

From March 2008 to February 2019, 51 patients with severe aortic valvulopathy (native SAS or degenerated aortic bioprosthesis) and CS treated by TAVI in 11 European centers were included in this multicenter registry. Demographic, clinical, and procedural data were collected, as well as clinical and echocardiographic follow-up.

RESULTS

The mean age of our study population was 75.8 ± 13, 49% were women, and mean Society of Thoracic Surgeons (STS) score was 19 ± 15%. Device success was achieved in 94.1%, with a 5% incidence of moderate/severe paravalvular leak. The 30-day events were mortality 11.8%, stroke 2.0%, vascular complications 5.9%, and acute kidney injury 34%. Valve Academic Research Consortium-2 early safety endpoint was reached in 35.3% of cases. At 1-year of follow-up, the mortality rate was 25.7% and the readmission for congestive heart failure was 8.6%.

CONCLUSIONS

TAVI seems to be a therapeutic option for patients with CS and SAS or degenerated aortic bioprosthesis in terms of both safety and efficacy at early and long-term follow-up.

Для цитирования: Fraccaro Chiara, Campante Teles Rui, Tchétché Didier, Saia Francesco, Bedogni Francesco, Montorfano Matteo, Fiorina Claudia, Meucci Francesco, De Benedictis Mauro, Leonzi Ornella, Barbierato Marco, Dumonteil Nicolas, Stolcova Miroslava, Maffeo Diego, Compagnone Miriam, Brito João, Chieffo Alaide, Tarantini Giuseppe. Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2020. DOI: 10.1002/ccd.29112.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.